These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 24121753)
1. Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival. Owor M; Mwatha A; Donnell D; Musoke P; Mmiro F; Allen M; Jackson JB; Fowler MG; Guay LA J Acquir Immune Defic Syndr; 2013 Dec; 64(5):464-71. PubMed ID: 24121753 [TBL] [Abstract][Full Text] [Related]
2. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118 [TBL] [Abstract][Full Text] [Related]
3. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Jackson JB; Musoke P; Fleming T; Guay LA; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Owor M; Ducar C; Deseyve M; Mwatha A; Emel L; Duefield C; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Gigliotti M; Bray D; Mmiro F Lancet; 2003 Sep; 362(9387):859-68. PubMed ID: 13678973 [TBL] [Abstract][Full Text] [Related]
4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. ; de Vincenzi I Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718 [TBL] [Abstract][Full Text] [Related]
5. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P; PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543 [TBL] [Abstract][Full Text] [Related]
6. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569 [TBL] [Abstract][Full Text] [Related]
7. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N; van der Merwe L; Brocklehurst P; Sint TT Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394 [TBL] [Abstract][Full Text] [Related]
8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490 [TBL] [Abstract][Full Text] [Related]
9. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine. Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; John-Stewart GC AIDS; 2005 Sep; 19(13):1415-22. PubMed ID: 16103773 [TBL] [Abstract][Full Text] [Related]
10. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Guay LA; Musoke P; Fleming T; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Ducar C; Deseyve M; Emel L; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Dransfield K; Bray D; Mmiro F; Jackson JB Lancet; 1999 Sep; 354(9181):795-802. PubMed ID: 10485720 [TBL] [Abstract][Full Text] [Related]
11. Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'Ivoire. Becquet R; Bequet L; Ekouevi DK; Viho I; Sakarovitch C; Fassinou P; Bedikou G; Timite-Konan M; Dabis F; Leroy V; PLoS Med; 2007 Jan; 4(1):e17. PubMed ID: 17227132 [TBL] [Abstract][Full Text] [Related]
12. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Newell ML; Borja MC; Peckham C; Pediatrics; 2003 Jan; 111(1):e52-60. PubMed ID: 12509595 [TBL] [Abstract][Full Text] [Related]
13. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M; JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785 [TBL] [Abstract][Full Text] [Related]
14. Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya. Kiarie JN; Kreiss JK; Richardson BA; John-Stewart GC AIDS; 2003 Jan; 17(1):65-71. PubMed ID: 12478070 [TBL] [Abstract][Full Text] [Related]
15. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983 [TBL] [Abstract][Full Text] [Related]
16. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study. Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS; Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351 [TBL] [Abstract][Full Text] [Related]
17. Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics. Venkatesh KK; Lurie MN; Triche EW; De Bruyn G; Harwell JI; McGarvey ST; Gray GE Trop Med Int Health; 2010 Nov; 15(11):1364-74. PubMed ID: 20955499 [TBL] [Abstract][Full Text] [Related]
18. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study. Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797 [TBL] [Abstract][Full Text] [Related]
19. Single-dose Nevirapine during pregnancy. Sax PE AIDS Clin Care; 1999 Oct; 11(10):84-5. PubMed ID: 11366708 [TBL] [Abstract][Full Text] [Related]
20. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV. Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]